Clinical Trial: Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis

U.S., Jan. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06792344) titled 'Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis' on Dec. 23, 2024.

Brief Summary: This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-CD19 CAR-T cells in the treatment of childhood-onset systemic sclerosis

Study Start Date: Dec. 15, 2024

Study Type: INTERVENTIONAL

Condition: Systemic Sclerosis (SSc)

Intervention: OTHER: anti-CD19 CAR-T cells

Intravenous injection the targeting CD19 CAR T cell

DRUG: anti-CD19 CAR-T cells

CD19-targeting CAR-T cells

Recruitment Status: RECRUITING

Sponsor: The Children's Hospital of Zhejiang University School of Medicine

I...